
Doximity (DOCS) Stock Forecast & Price Target
Doximity (DOCS) Analyst Ratings
Bulls say
Doximity is poised for long-term growth due to its strong network and innovative solutions for medical professionals, despite challenges such as market competition and budget constraints. Its impressive financials, including a 58% increase in revenue in 2020 and a strong balance sheet with $1.2 billion in cash, further support this positive outlook. Additionally, with hospitals increasingly utilizing digital solutions, Doximity stands to benefit from the growing adoption of telemedicine and virtual patient visits.
Bears say
Doximity is experiencing slower growth and GM compression due to increased investments in AI, while regulatory uncertainty has resulted in delayed deal signings and a lowered revenue guidance for FY26. Despite a high adoption rate for AI tools, it remains unclear how it will impact financials, and competitor OpenEvidence's entry into the market may pose a threat. With fluctuating growth and uncertainties in the regulatory landscape, the financial outlook for Doximity is unfavorable.
This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.
Doximity (DOCS) Analyst Forecast & Price Prediction
Start investing in Doximity (DOCS)
Order type
Buy in
Order amount
Est. shares
0 shares